NewsBenzingaTakeda Pharmaceutical Q2 Adj. EPS $0.48 Beats $0.31 Estimate, Sales $7.457B Beat $7.190B Estimate Takeda Pharmaceutical Q2 Adj. EPS $0.48 Beats $0.31 Estimate, Sales $7.457B Beat $7.190B Estimate Benzinga 2026.10.29 07:57 (GMT+0) Open on Benzinga Other news Building A 7%-Yielding Dividend Growth Portfolio With SCHD As Its Core Holding Lilly raises outlook for third time this year as Zepbound sales soar WPP plc (WPP) Q3 2026 Sales/ Trading Statement Call - Slideshow (NYSE:WPP) 2026-10-29 AutoZone's Q1 2027 Earnings: What to Expect Shopify Bull Put Spread Could Return 25% Coherus Oncology, Inc. (CHRS) Discusses Tagmokitug Interim Clinical Data in Esophageal Cancer Transcript
Coherus Oncology, Inc. (CHRS) Discusses Tagmokitug Interim Clinical Data in Esophageal Cancer Transcript
